191 related articles for article (PubMed ID: 12441073)
1. Mechanism of neutralization of influenza virus infectivity by antibodies.
Knossow M; Gaudier M; Douglas A; Barrère B; Bizebard T; Barbey C; Gigant B; Skehel JJ
Virology; 2002 Oct; 302(2):294-8. PubMed ID: 12441073
[TBL] [Abstract][Full Text] [Related]
2. Dissection of Epitope-Specific Mechanisms of Neutralization of Influenza Virus by Intact IgG and Fab Fragments.
Williams JA; Gui L; Hom N; Mileant A; Lee KK
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263254
[TBL] [Abstract][Full Text] [Related]
3. Is bivalent binding of monoclonal antibodies to different antigenic areas on the hemagglutinin of influenza virus required for neutralization of viral infectivity?
Yoden S; Kida H; Yanagawa R
Arch Virol; 1985; 85(3-4):209-16. PubMed ID: 2411245
[TBL] [Abstract][Full Text] [Related]
4. A haemagglutinin (HA1)-specific FAb neutralizes influenza A virus by inhibiting fusion activity.
Edwards MJ; Dimmock NJ
J Gen Virol; 2001 Jun; 82(Pt 6):1387-1395. PubMed ID: 11369883
[TBL] [Abstract][Full Text] [Related]
5. Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event.
Edwards MJ; Dimmock NJ
J Virol; 2001 Nov; 75(21):10208-18. PubMed ID: 11581389
[TBL] [Abstract][Full Text] [Related]
6. Variations in the neutralizing and haemagglutination-inhibiting activities of five influenza A virus-specific IgGs and their antibody fragments.
Schofield DJ; Stephenson JR; Dimmock NJ
J Gen Virol; 1997 Oct; 78 ( Pt 10)():2431-9. PubMed ID: 9349461
[TBL] [Abstract][Full Text] [Related]
7. Virus-neutralizing activity mediated by the Fab fragment of a hemagglutinin-specific antibody is sufficient for the resolution of influenza virus infection in SCID mice.
Mozdzanowska K; Feng J; Gerhard W
J Virol; 2003 Aug; 77(15):8322-8. PubMed ID: 12857901
[TBL] [Abstract][Full Text] [Related]
8. Quantitative relationships between an influenza virus and neutralizing antibody.
Taylor HP; Armstrong SJ; Dimmock NJ
Virology; 1987 Aug; 159(2):288-98. PubMed ID: 3617501
[TBL] [Abstract][Full Text] [Related]
9. Relating influenza virus membrane fusion kinetics to stoichiometry of neutralizing antibodies at the single-particle level.
Otterstrom JJ; Brandenburg B; Koldijk MH; Juraszek J; Tang C; Mashaghi S; Kwaks T; Goudsmit J; Vogels R; Friesen RH; van Oijen AM
Proc Natl Acad Sci U S A; 2014 Dec; 111(48):E5143-8. PubMed ID: 25404330
[TBL] [Abstract][Full Text] [Related]
10. Heterosubtypic antibodies to influenza A virus have limited activity against cell-bound virus but are not impaired by strain-specific serum antibodies.
Wyrzucki A; Bianchi M; Kohler I; Steck M; Hangartner L
J Virol; 2015 Mar; 89(6):3136-44. PubMed ID: 25552718
[TBL] [Abstract][Full Text] [Related]
11. High and low efficiency neutralization epitopes on the haemagglutinin of type A influenza virus.
Schofield DJ; Stephenson JR; Dimmock NJ
J Gen Virol; 1997 Oct; 78 ( Pt 10)():2441-6. PubMed ID: 9349462
[TBL] [Abstract][Full Text] [Related]
12. Structural Insights into Reovirus σ1 Interactions with Two Neutralizing Antibodies.
Dietrich MH; Ogden KM; Katen SP; Reiss K; Sutherland DM; Carnahan RH; Goff M; Cooper T; Dermody TS; Stehle T
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928010
[TBL] [Abstract][Full Text] [Related]
13. Fab MAbs specific to HA of influenza virus with H5N1 neutralizing activity selected from immunized chicken phage library.
Pitaksajjakul P; Lekcharoensuk P; Upragarin N; Barbas CF; Ibrahim MS; Ikuta K; Ramasoota P
Biochem Biophys Res Commun; 2010 May; 395(4):496-501. PubMed ID: 20382115
[TBL] [Abstract][Full Text] [Related]
14. Antibody 27F3 Broadly Targets Influenza A Group 1 and 2 Hemagglutinins through a Further Variation in V
Lang S; Xie J; Zhu X; Wu NC; Lerner RA; Wilson IA
Cell Rep; 2017 Sep; 20(12):2935-2943. PubMed ID: 28930686
[TBL] [Abstract][Full Text] [Related]
15. Neutralization of poliovirus by a monoclonal antibody: kinetics and stoichiometry.
Icenogle J; Shiwen H; Duke G; Gilbert S; Rueckert R; Anderegg J
Virology; 1983 Jun; 127(2):412-25. PubMed ID: 6306918
[TBL] [Abstract][Full Text] [Related]
16. Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies.
Mazanec MB; Coudret CL; Fletcher DR
J Virol; 1995 Feb; 69(2):1339-43. PubMed ID: 7815518
[TBL] [Abstract][Full Text] [Related]
17. Interaction of hydrophobized antiviral antibodies with influenza virus infected MDCK cells.
Melik-Nubarov NS; Suzdaltseva YuG ; Priss EL; Slepnev VI; Kabanov AV; Zhirnov OP; Sveshnikov PG; Severin ES
Biochem Mol Biol Int; 1993 Apr; 29(5):939-47. PubMed ID: 8508145
[TBL] [Abstract][Full Text] [Related]
18. An epitope shared by the hemagglutinins of H1, H2, H5, and H6 subtypes of influenza A virus.
Smirnov YA; Lipatov AS; Gitelman AK; Okuno Y; Van Beek R; Osterhaus AD; Claas EC
Acta Virol; 1999 Aug; 43(4):237-44. PubMed ID: 10749369
[TBL] [Abstract][Full Text] [Related]
19. Fusion of influenza virus with the endosomal membrane is inhibited by monoclonal antibodies to defined epitopes on the hemagglutinin.
Imai M; Sugimoto K; Okazaki K; Kida H
Virus Res; 1998 Feb; 53(2):129-39. PubMed ID: 9620205
[TBL] [Abstract][Full Text] [Related]
20. Dissociation of the haemagglutination inhibition and the infectivity neutralization in the reactions of influenza A/USSR/90/77 (H1N1) virus variants with monoclonal antibodies.
Gitelman AK; Kaverin NV; Kharitonenkov IG; Rudneva IA; Sklyanskaya EL; Zhdanov VM
J Gen Virol; 1986 Oct; 67 ( Pt 10)():2247-51. PubMed ID: 3760825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
